微生物鑑定市場規模、佔有率和成長分析(按產品/服務、方法、技術、應用、最終用戶和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1897856

微生物鑑定市場規模、佔有率和成長分析(按產品/服務、方法、技術、應用、最終用戶和地區分類)-2026-2033年產業預測

Microbial Identification Market Size, Share, and Growth Analysis, By Product & Service (Instruments & Software, Consumables, Panels/Id Cards & Media), By Method, By Technology, By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球微生物鑑定市場規模預計在 2024 年達到 50.6 億美元,從 2025 年的 56.9 億美元成長到 2033 年的 144.9 億美元,在預測期(2026-2033 年)內複合年成長率為 12.4%。

全球微生物鑑定市場受感染疾病流行趨勢和分子診斷技術進步的驅動,使其成為診斷和微生物學領域的關鍵組成部分。全球化、都市化和氣候變遷等因素促使人們對高效微生物鑑定技術的需求不斷成長。次世代定序、PCR和質譜等創新技術提高了鑑定的準確性和速度,進一步推動了市場擴張。衛生部門日益增強的意識和支持凸顯了感染疾病防治的重要性,從而確保了相關措施所需的資金和資源。然而,高昂的前期成本、複雜的微生物鑑定程序和嚴格的監管要求等挑戰可能會阻礙市場成長,尤其是在發展中地區。儘管如此,就地檢驗的進步、人工智慧的整合以及新興研究市場需求的成長,正在創造新的成長機會。

全球微生物鑑定市場促進因素

食源性疾病和感染疾病的日益增加凸顯了嚴格食品安全通訊協定的重要性。因此,監管機構正強制要求食品生產商和製造商實施嚴格的微生物檢測標準和規範。這種對食品安全的日益重視正在推動食品飲料行業的市場擴張。為了滿足不斷成長的安全需求,企業更加重視採用全面的微生物鑑定技術,從而促進了全球微生物鑑定市場的創新和成長。持續改進食品安全措施的努力不斷塑造產業實踐,並推動市場發展。

限制全球微生物鑑定市場的因素

微生物鑑定和表徵面臨許多挑戰,需要專業的知識和技能。這種固有的複雜性使得許多實驗室和醫療機構對採用先進的系統和技術猶豫不決,尤其是在資源有限、技術培訓不足的地區。因此,缺乏先進工具和熟練人員可能會阻礙該領域創新技術的廣泛應用,進而威脅到全球微生物鑑定市場的擴張。因此,克服這些障礙對於促進微生物鑑定實踐的成長至關重要。

全球微生物鑑定市場趨勢

在次世代定序和聚合酵素鏈鎖反應(PCR) 等技術進步的推動下,快速分子診斷方法的應用已成為全球微生物鑑定市場的一大趨勢。這項轉變凸顯了快速且準確地鑑定病原體的重要性,使醫療專業人員能夠及時做出明智的治療決策。與傳統的培養方法相比,這些分子技術具有更高的靈敏度和更快的檢測速度,透過早期診斷改善患者預後。隨著醫療保健產業將精準醫療置於優先地位並不斷提高診斷效率,對創新型微生物鑑定解決方案的需求預計將顯著成長,從而重塑市場格局。

目錄

介紹

  • 調查目標
  • 定義
  • 市場覆蓋範圍

調查方法

  • 資訊收集
  • 二手和一手資料資訊來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

    前景
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場動態
    • 促進要素
    • 機會
    • 抑制因素
    • 任務
  • 波特分析

關鍵市場考察

  • 技術分析
  • 價值鏈分析
  • 市場生態系統
  • 供應鏈分析
  • 案例研究分析
  • 監管環境
  • 創新矩陣
  • 主要投資分析
  • 關鍵成功因素
  • 競爭程度

微生物鑑定市場(按產品/服務分類)

  • 設備和軟體
  • 消耗品
    • 面板/ID卡和培養基
    • 成套工具
    • 其他消耗品
  • 服務

依方法分類的微生物鑑定市場

  • 表現型法
  • 基於蛋白質體學的方法
  • 基因分型方法

按技術分類的微生物鑑定市場

  • 基於質譜的微生物鑑定市場
  • 基於PCR的微生物鑑定市場
  • 基於流式細胞技術的微生物鑑定市場
  • 基於顯微鏡的微生物鑑定市場
  • 其他微生物鑑定技術

微生物鑑定市場依應用領域分類

  • 診斷用途
    • 人類疾病診斷
    • 動物疾病診斷
  • 藥物用途
  • 食品檢驗
  • 飲料檢驗
  • 化妝品和個人保健產品測試
  • 環境應用
  • 其他用途

按最終用戶分類的微生物鑑定市場

  • 醫院、診斷檢查室和血庫
  • 製藥公司和合約研究組織
  • 食品製造公司
  • 飲料製造公司
  • 其他最終用戶

微生物鑑定市場:按地區分類的市場規模:

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲(MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭格局

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市佔率(2025 年)

主要企業簡介

  • BioMerieux SA(France)
  • Becton, Dickinson and Company(BD)(US)
  • Thermo Fisher Scientific Inc.(US)
  • Danaher Corporation(US)
  • Merck KGaA(Germany)
  • Bruker Corporation(US)
  • Shimadzu Corporation(Japan)
  • Qiagen NV(Netherlands)
  • Avantor, Inc.(US)
  • Accelerate Diagnostics, Inc.(US)
  • Biolog, Inc.(US)
  • Liofilchem Srl(Italy)
  • Trivitron Healthcare(India)
  • Gradian Diagnostics(US)
  • Alifax Srl(Italy)
  • HiMedia Laboratories(India)
  • i2a SA(France)
  • Zhuhai DL Biotech Co., Ltd.(China)
  • GeneFluidics, Inc.(US)
  • Creative Diagnostics(US)
簡介目錄
Product Code: SQMIG35J2067

Global Microbial Identification Market size was valued at USD 5.06 Billion in 2024 and is poised to grow from USD 5.69 Billion in 2025 to USD 14.49 Billion by 2033, growing at a CAGR of 12.4% during the forecast period (2026-2033).

The global microbial identification market represents a crucial sector within diagnostics and microbiology, driven by an increasing prevalence of infectious diseases and advancements in molecular diagnostics. Factors such as globalization, urbanization, and climate change contribute to rising demand for effective microbial identification technologies. Innovations like next-generation sequencing, PCR, and mass spectrometry enhance accuracy and speed, further propelling market expansion. Increased awareness and support from health organizations highlight the importance of controlling infectious diseases, leading to necessary funding and resources for relevant initiatives. However, challenges such as high initial costs, complexity in microbial identification procedures, and stringent regulatory requirements could hinder market growth, particularly in developing regions. Nevertheless, growth opportunities emerge through advancements in point-of-care testing and AI integration, coupled with rising demand in emerging research markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbial Identification market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbial Identification Market Segments Analysis

Global Microbial Identification Market is segmented by Product & Service, Method, Technology, Application, End User, and region. Based on Product & Service, the market is segmented into Instruments & Software, Consumables, and Services. Based on Method, the market is segmented into Phenotypic Methods, Proteomics-Based Methods, and Genotypic Methods. Based on Technology, the market is segmented into Mass Spectrometry-Based Microbial Identification Market, PCR Based Microbial Identification Market, Flow Cytometry Based Microbial Identification Market, Microscopy Based Microbial Identification Market, and Other Microbial Identification Technologies. Based on Application, the market is segmented into Diagnostic Applications Pharmaceutical Applications, Food Testing, Beverage Testing, Cosmetics and Personal Care Products Testing, Environmental Applications, and Other Applications. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Blood Banks, Pharmaceutical Companies & Contract Research Organizations, Food Manufacturing Companies, Beverage Manufacturing Companies, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Microbial Identification Market

The increasing incidence of foodborne illnesses and infections has heightened the emphasis on stringent food safety protocols. As a result, regulatory agencies are urging food producers and manufacturers to implement rigorous microbial testing standards and practices. This heightened focus on ensuring food safety is propelling market expansion within the food and beverage sector. Companies are becoming more vigilant in adopting comprehensive microbial identification techniques to meet these elevated safety demands, thus fostering innovation and growth in the global microbial identification market. The ongoing commitment to improving food safety measures continues to shape industry practices and drive market development.

Restraints in the Global Microbial Identification Market

The identification and characterization of microorganisms presents significant challenges that require specialized expertise and skills. This inherent complexity can deter many laboratories and healthcare providers from embracing advanced systems and technologies, particularly in areas with limited resources and inadequate technical training. Consequently, these issues can impede the expansion of the Global Microbial Identification market, as the lack of accessibility to advanced tools and the need for skilled personnel may hinder widespread adoption and utilization of innovation in the field. As a result, overcoming these barriers becomes essential for fostering growth and enhancing microbial identification practices.

Market Trends of the Global Microbial Identification Market

The global microbial identification market is witnessing a significant trend towards the adoption of rapid molecular diagnostics, propelled by advancements in technologies such as next-generation sequencing and polymerase chain reaction (PCR). This shift emphasizes the need for swift and accurate identification of pathogens, enabling healthcare providers to make timely and informed treatment decisions. These molecular techniques offer superior sensitivity and faster turnaround times compared to traditional culture-based methods, enhancing patient outcomes through early diagnosis. As healthcare continues to prioritize precision medicine and improve diagnostic efficiency, the demand for innovative microbial identification solutions is expected to increase significantly, transforming the market landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Supply chain Analysis
  • Case study Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Microbial Identification Market by Product & Service

  • Market Overview
  • Instruments & Software
  • Consumables
    • Panels/Id Cards & Media
    • Kits
    • Other Consumables
  • Services

Microbial Identification Market by Method

  • Market Overview
  • Phenotypic Methods
  • Proteomics-Based Methods
  • Genotypic Methods

Microbial Identification Market by Technology

  • Market Overview
  • Mass Spectrometry-Based Microbial Identification Market
  • PCR Based Microbial Identification Market
  • Flow Cytometry Based Microbial Identification Market
  • Microscopy Based Microbial Identification Market
  • Other Microbial Identification Technologies

Microbial Identification Market by Application

  • Market Overview
  • Diagnostic Applications
    • Human Disease Diagnosis
    • Animal Disease Diagnosis
  • Pharmaceutical Applications
  • Food Testing
  • Beverage Testing
  • Cosmetics And Personal Care Products Testing
  • Environmental Applications
  • Other Applications

Microbial Identification Market, By End User

  • Hospitals, Diagnostic Laboratories, and Blood Banks
  • Pharmaceutical Companies & Contract Research Organizations
  • Food Manufacturing Companies
  • Beverage Manufacturing Companies
  • Other End Users

Microbial Identification Market Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2025

Key Company Profiles

  • BioMerieux SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company (BD) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen NV (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avantor, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Accelerate Diagnostics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biolog, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Liofilchem S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Trivitron Healthcare (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gradian Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Alifax S.r.l. (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HiMedia Laboratories (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • i2a SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zhuhai DL Biotech Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GeneFluidics, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Creative Diagnostics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments